Table 5 FDA-approved CART T-cell therapies
From: Review of cancer therapies for the perioperative physician
Name | Trade name | Antigen | Disease |
|---|---|---|---|
Tisagenlecleucel | Kymriah | CD19 | ALL, NHL |
Axicabtagene ciloleucel | Yescarta | CD19 | NHL, follicular lymphoma |
Brexucabtagene autoleucel | Tecartus | CD19 | Mantle cell lymphoma (MCL), ALL |
Lisocabtagene maraleucel | Breyanzi | CD19 | NHL |
Idecabtagene vicleucel | Abecma | BCMA | Multiple myeloma (MM) |
Ciltacabtagene autoleucel | Carvykti | BCMA | Multiple myeloma (MM) |